Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 2443

1.

A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.

Bellack AS, Bennett ME, Gearon JS, Brown CH, Yang Y.

Arch Gen Psychiatry. 2006 Apr;63(4):426-32.

PMID:
16585472
2.

Behavioral interventions for dual-diagnosis patients.

Goldsmith RJ, Garlapati V.

Psychiatr Clin North Am. 2004 Dec;27(4):709-25. Review.

PMID:
15550289
3.

Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment.

Baker KD, Lubman DI, Cosgrave EM, Killackey EJ, Yuen HP, Hides L, Baksheev GN, Buckby JA, Yung AR.

Aust N Z J Psychiatry. 2007 Nov;41(11):896-902.

PMID:
17924242
4.

Group intervention for coexisting psychosis and substance use disorders in rural Australia: outcomes over 3 years.

Bradley AC, Baker A, Lewin TJ.

Aust N Z J Psychiatry. 2007 Jun;41(6):501-8.

PMID:
17508320
5.

Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (dual diagnosis): a review of empirical evidence.

Horsfall J, Cleary M, Hunt GE, Walter G.

Harv Rev Psychiatry. 2009;17(1):24-34. doi: 10.1080/10673220902724599. Review.

PMID:
19205964
6.

[Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].

Guillem E, Pelissolo A, Vorspan F, Bouchez-Arbabzadeh S, Lépine JP.

Encephale. 2009 Jun;35(3):226-33. doi: 10.1016/j.encep.2008.03.010. Epub 2008 Aug 19. French.

PMID:
19540408
7.

A national study of violent behavior in persons with schizophrenia.

Swanson JW, Swartz MS, Van Dorn RA, Elbogen EB, Wagner HR, Rosenheck RA, Stroup TS, McEvoy JP, Lieberman JA.

Arch Gen Psychiatry. 2006 May;63(5):490-9.

PMID:
16651506
8.

Implications of mental and substance use disorders. A comparison of single and dual diagnosis patients.

Lehman AF, Myers CP, Thompson JW, Corty E.

J Nerv Ment Dis. 1993 Jun;181(6):365-70.

PMID:
8388914
9.

Utilization of mental health and substance abuse care for people living with HIV/AIDS, chronic mental illness, and substance abuse disorders.

Weaver MR, Conover CJ, Proescholdbell RJ, Arno PS, Ang A, Ettner SL; Cost Subcommittee of the HIV/AIDS Treatment Adherence, Health Outcomes, and Cost Study Group.

J Acquir Immune Defic Syndr. 2008 Apr 1;47(4):449-58. doi: 10.1097/QAI.0b013e3181642244.

PMID:
18197121
10.

Prevalence and severity of substance use disorders and onset of psychosis in first-admission psychotic patients.

Rabinowitz J, Bromet EJ, Lavelle J, Carlson G, Kovasznay B, Schwartz JE.

Psychol Med. 1998 Nov;28(6):1411-9.

PMID:
9854282
11.

Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior.

Hogarty GE, Flesher S, Ulrich R, Carter M, Greenwald D, Pogue-Geile M, Kechavan M, Cooley S, DiBarry AL, Garrett A, Parepally H, Zoretich R.

Arch Gen Psychiatry. 2004 Sep;61(9):866-76.

PMID:
15351765
12.

Randomized controlled trial of cognitive behavioral social skills training for older people with schizophrenia: 12-month follow-up.

Granholm E, McQuaid JR, McClure FS, Link PC, Perivoliotis D, Gottlieb JD, Patterson TL, Jeste DV.

J Clin Psychiatry. 2007 May;68(5):730-7.

PMID:
17503982
13.

The effectiveness of telephone-based continuing care for alcohol and cocaine dependence: 24-month outcomes.

McKay JR, Lynch KG, Shepard DS, Pettinati HM.

Arch Gen Psychiatry. 2005 Feb;62(2):199-207.

PMID:
15699297
14.

Integrated treatment for dually diagnosed homeless adults.

Drake RE, Yovetich NA, Bebout RR, Harris M, McHugo GJ.

J Nerv Ment Dis. 1997 May;185(5):298-305.

PMID:
9171806
15.

Long-term effectiveness and cost of a systematic care program for bipolar disorder.

Simon GE, Ludman EJ, Bauer MS, Unützer J, Operskalski B.

Arch Gen Psychiatry. 2006 May;63(5):500-8.

PMID:
16651507
16.

The prevalence of mental and physical health disorders among older methadone patients.

Rosen D, Smith ML, Reynolds CF 3rd.

Am J Geriatr Psychiatry. 2008 Jun;16(6):488-97. doi: 10.1097/JGP.0b013e31816ff35a.

PMID:
18515693
17.

The effects of substance use disorder on the clinical presentation of anxiety and depression in an outpatient psychiatric clinic.

Tsuang D, Cowley D, Ries R, Dunner DL, Roy-Byrne PP.

J Clin Psychiatry. 1995 Dec;56(12):549-55.

PMID:
8530330
18.

Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.

Weaver MR, Conover CJ, Proescholdbell RJ, Arno PS, Ang A, Uldall KK, Ettner SL.

J Ment Health Policy Econ. 2009 Mar;12(1):33-46.

PMID:
19346565
19.

Prevalence and characteristics of clients with co-occurring disorders in outpatient substance abuse treatment.

Watkins KE, Hunter SB, Wenzel SL, Tu W, Paddock SM, Griffin A, Ebener P.

Am J Drug Alcohol Abuse. 2004 Nov;30(4):749-64.

PMID:
15624547
20.

Variables associated with alcohol, drug, and daily smoking cessation in patients with severe mental illnesses.

de Leon J, Susce MT, Diaz FJ, Rendon DM, Velásquez DM.

J Clin Psychiatry. 2005 Nov;66(11):1447-55.

PMID:
16420083

Supplemental Content

Support Center